Mycophenolate mofetil Recruiting Phase 2 Trials for Epidermolysis Bullosa Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02582775MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs